Depression News and Research

Latest Depression News and Research

Disparities in managing depression among HIV-positive pregnant women

It seems logical that programs to screen and manage depression in pregnant, HIV-positive Medicaid patients should already be in place, but they aren't. It's the kind of glaring oversight that Rajesh Balkrishnan, associate professor at the University of Michigan College of Pharmacy, said he finds all the time in his research on health disparities.

13 Jun 2012

Acute and chronic elevation of EPO in the brain improve motivation for exercise

As science rushes to develop safe weight loss drugs, a new research report approaches this problem from an entirely new angle: What if there were a pill that would make you want to exercise harder? It may sound strange, but a new research report appearing online in The FASEB Journal suggests that it might be possible.

13 Jun 2012

Two studies report sleep disparities among Americans based on racial and ethnic background

Two studies scheduled for presentation today at SLEEP 2012 are reporting sleep disparities among Americans based on racial and ethnic background.

13 Jun 2012

Depression, obesity two main culprits of excessive daytime sleepiness

Wake up, America, and lose some weight - it's keeping you tired and prone to accidents. Three studies being presented today at sleep 2012 conclude that obesity and depression are the two main culprits making us excessively sleepy while awake.

13 Jun 2012

Gut microbes regulate brain levels of serotonin

UCC scientists have shown that brain levels of serotonin, the 'happy hormone' are regulated by the amount of bacteria in the gut during early life. Their research is being published today in the leading international psychiatry journal, Molecular Psychiatry.

13 Jun 2012

Positive airway pressure reduces depressive symptoms in patients with OSA

Patients seen at the Cleveland Clinic Sleep Disorders Center who used positive airway pressure (PAP) to treat their obstructive sleep apnea (OSA) had improvements in their depressive symptoms, even if they followed the prescribed PAP regimen only partly, a new study reports.

12 Jun 2012

Mindfulness can help cancer patients with anxiety and depression

When being diagnosed with cancer, people will naturally worry about their future, their family and about dying. Actually, no less than 35-40% of cancer patients suffer from significant anxiety and depression symptoms. An interdisciplinary research project carried out between Aarhus University, Business and Social Sciences and Aarhus University Hospital and the Danish Cancer Society now shows that mindfulness can help cancer those patients suffering from anxiety and depression.

12 Jun 2012

ABM treatments can address childhood anxiety

According to the Anxiety and Depression Association of America, one in eight children suffers from an anxiety disorder. And because many anxious children turn into severely anxious adults, early intervention can have a major impact on a patient's life trajectory. The understandable reluctance to use psychiatric medications when it comes to children means child psychologists are always searching for viable therapeutic alternatives.

12 Jun 2012

Cyberonics, Imricor enter agreement to develop MRI compatible leads for VNS Therapy System

Cyberonics, Inc. today announced that it has entered into an exclusive technology license agreement with Imricor Medical Systems, Inc. to develop Magnetic Resonance Imaging ("MRI") compatible leads for use with the VNS Therapy System (Vagus Nerve Stimulation).

11 Jun 2012

Adult fear of the dark may contribute to insomnia

A small study of Toronto college students is shedding light on a contributing factor of insomnia that might be hard to admit - an adult fear of the dark.

11 Jun 2012

Epo has performance-enhancing effect on brain, may help treat depression, schizophrenia

Sportsmen and women dope with the blood hormone Epo to enhance their performance. Researchers from the University of Zurich now discovered by animal testing that Epo has a performance-enhancing effect in the brain shortly after injection and not only after days by improving oxygen transport in blood. As Epo also increases motivation, it could be useful in treating depression.

11 Jun 2012

Short sleep periods increase risk of stroke in normal-weight adults

Habitually sleeping less than six hours a night significantly increases the risk of stroke symptoms among middle-age to older adults who are of normal weight and at low risk for obstructive sleep apnea (OSA), according to a study of 5,666 people followed for up to three years.

11 Jun 2012

Amylin, Alkermes announce results from BYDUREON clinical study on type 2 diabetes

Amylin Pharmaceuticals, Inc. and Alkermes plc today announced results from the long-term extension of the DURATION-1 study, which showed that BYDUREON (exenatide extended-release for injectable suspension), the first and only once-weekly treatment for type 2 diabetes, was associated with clinically significant and sustained improvements in glycemic control during four years of treatment in adults with type 2 diabetes.

11 Jun 2012

Adolescent mental disorders have repercussions for addiction

Adolescents with mental health disorders are significantly more likely to become addicted to prescription opioid pain relievers than those without mental disorders, experts say.

8 Jun 2012

Mania develops in late adolescence

There is an increasing prevalence of bipolar disorder over adolescence, with late adolescence the peak period for the development of mania, research shows.

8 Jun 2012

Research roundup: Savings from electronic health records?

Does Health Information Exchange Reduce Unnecessary Neuroimaging and Improve Quality of Headache Care in the Emergency Department?

8 Jun 2012

Special section of JNMD focuses on the impending release of revised DSM-5

The June issue of The Journal of Nervous and Mental Disease (JNMD) features a special section focused on the impending release of the revised Diagnostic and Statistical Manual of Mental Disorders (DSM-5), an update to psychiatric diagnosis standards.

8 Jun 2012

New study into pain associated with diabetes

Researchers in Sheffield have been awarded over £310,000 to carry out a study that could help revolutionise the way clinicians treat the pain experienced by thousands of people with diabetes.

8 Jun 2012

FDA approves XenoPort, GSK’s Horizant ER tablets for management of PHN

GlaxoSmithKline plc (GSK) and XenoPort, Inc. announced today that the United States (US) Food and Drug Administration (FDA) has approved Horizant (gabapentin enacarbil) Extended-Release Tablets for the management of postherpetic neuralgia (PHN) in adults.

7 Jun 2012

Young adults, adolescents with mental health disorders more likely to become long-term opioid users

Long-term use and abuse of opioid painkillers, such as OxyContin and Vicodin, has markedly increased in the United States in the last two decades. Of note, prescription opioids constitute 86.9 percent of prescription drug misuse among high school students. And last week in a two-day U.S. Food and Drug Administration public meeting, officials questioned the use of long-term opioids for chronic pain due to a lack of evidence for the effectiveness and concerns about the potential risk for addiction.

7 Jun 2012

Depression News and Research

Latest Depression News and Research

Disparities in managing depression among HIV-positive pregnant women

Acute and chronic elevation of EPO in the brain improve motivation for exercise

Two studies report sleep disparities among Americans based on racial and ethnic background

Depression, obesity two main culprits of excessive daytime sleepiness

Gut microbes regulate brain levels of serotonin

Positive airway pressure reduces depressive symptoms in patients with OSA

Mindfulness can help cancer patients with anxiety and depression

ABM treatments can address childhood anxiety

Cyberonics, Imricor enter agreement to develop MRI compatible leads for VNS Therapy System

Adult fear of the dark may contribute to insomnia

Epo has performance-enhancing effect on brain, may help treat depression, schizophrenia

Short sleep periods increase risk of stroke in normal-weight adults

Amylin, Alkermes announce results from BYDUREON clinical study on type 2 diabetes

Adolescent mental disorders have repercussions for addiction

Mania develops in late adolescence

Research roundup: Savings from electronic health records?

Special section of JNMD focuses on the impending release of revised DSM-5

New study into pain associated with diabetes

FDA approves XenoPort, GSK’s Horizant ER tablets for management of PHN

Young adults, adolescents with mental health disorders more likely to become long-term opioid users

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Depression News and Research

Latest Depression News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in